212 related articles for article (PubMed ID: 21688620)
21. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.
Wallace JL; Syer S; Denou E; de Palma G; Vong L; McKnight W; Jury J; Bolla M; Bercik P; Collins SM; Verdu E; Ongini E
Gastroenterology; 2011 Oct; 141(4):1314-22, 1322.e1-5. PubMed ID: 21745447
[TBL] [Abstract][Full Text] [Related]
22. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
23. Prevention of traditional NSAID-induced small intestinal injury: recent preliminary studies using capsule endoscopy.
Fujimori S; Takahashi Y; Seo T; Gudis K; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
Digestion; 2010; 82(3):167-72. PubMed ID: 20588029
[TBL] [Abstract][Full Text] [Related]
24. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D
J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
[TBL] [Abstract][Full Text] [Related]
25. Gastrointestinal lesions during treatment with non-steroidal anti-inflammatory drugs (NSAIDs).
Festen HP
Neth J Med; 1989 Dec; 35(5-6):327-33. PubMed ID: 2699655
[TBL] [Abstract][Full Text] [Related]
26. Review article: cellular and molecular mechanisms of NSAID-induced peptic ulcers.
Musumba C; Pritchard DM; Pirmohamed M
Aliment Pharmacol Ther; 2009 Sep; 30(6):517-31. PubMed ID: 19575764
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori infection and the use of NSAIDs.
Bazzoli F; De Luca L; Graham DY
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
[TBL] [Abstract][Full Text] [Related]
28. Ulcers, Helicobacter pylori infection, platelets and gastrointestinal complications of non-steroidal anti-inflammatory drugs: what are the connections?
McCarthy DM
Eur J Surg Suppl; 2002; (587):89-99. PubMed ID: 16144207
[TBL] [Abstract][Full Text] [Related]
29. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy.
McCarthy DM
J Clin Gastroenterol; 1990; 12 Suppl 2():S13-20. PubMed ID: 1978842
[TBL] [Abstract][Full Text] [Related]
30. Primary prevention of ulcers in patients taking aspirin or NSAIDs.
Med Lett Drugs Ther; 2010 Mar; 52(1333):17-9. PubMed ID: 20300052
[TBL] [Abstract][Full Text] [Related]
31. [Treatment and prevention of NSAIDs-induced gastrointestinal injury--the role of gastroenterologist].
Yamamoto T; Kuyama Y
Nihon Rinsho; 2011 Jun; 69(6):1072-4. PubMed ID: 21688630
[TBL] [Abstract][Full Text] [Related]
32. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
Scarpignato C; Pelosini I
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
[TBL] [Abstract][Full Text] [Related]
33. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
[TBL] [Abstract][Full Text] [Related]
34. [Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy].
Lanas A
Rev Gastroenterol Mex; 2004; 69(4):251-60. PubMed ID: 15765979
[TBL] [Abstract][Full Text] [Related]
35. [Curative and preventive treatment of NSAID-associated gastroduodenal ulcers].
Dupas JL; Grigy C
Gastroenterol Clin Biol; 2004 Apr; 28 Spec No 3():C77-83. PubMed ID: 15366678
[TBL] [Abstract][Full Text] [Related]
36. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs].
Fialová P; Vlcek J
Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967
[TBL] [Abstract][Full Text] [Related]
37. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
Scheiman JM; Hindley CE
Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236
[TBL] [Abstract][Full Text] [Related]
38. Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies.
Lanas A; Hunt R
Ann Med; 2006; 38(6):415-28. PubMed ID: 17008305
[TBL] [Abstract][Full Text] [Related]
39. [Treatment and prevention of gastrointestinal complications caused by non-steroidal antiphlogistic agents].
Rybár I; Kriska M; Vavrecka A; Hyrdel R; Rovenský J
Cas Lek Cesk; 1999 Nov; 138(22):675-80. PubMed ID: 10746025
[TBL] [Abstract][Full Text] [Related]
40. [Pathogenesis of NSAIDs-induced gastrointestinal ulcers].
Yoshikawa T; Naito Y
Nihon Rinsho; 2011 Jun; 69(6):995-1002. PubMed ID: 21688618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
